About the Journal
Focus and Scope
An initial in-house quality control check deals with issues such as competing interests, financial disclosures, plagiarism, etc. Submissions may be returned to authors for queries, and will not be seen by our Editorial Board or peer reviewers until they pass this quality control check.
After the quality control check, the Editor of the journal reviews the article, and decides if the article is accepted for review or rejected. In some cases, where an article is submitted in English, by an author not fluent in English, the article may be sent back with the recommendations to have the article edited for English, and resubmitted.
Once an article has been accepted, it will be sent to a selected editorial board member, based on experience and expertise. The Editorial Board member will then either act as one of two peer reviewers, or will select two peer reviewers to review the article. Reviews are double blind.
Questions, comments, and suggestions from peer reviewers will be submitted to the Editor for consideration, after which the article and peer review remarks will be sent to the author.
Once the peer reviewer, Editorial Board member, and Editor are satisfied with the author's changes, the article will be published.
It is our goal to have accepted articles published within 45 days, depending on the level of response from the authors.
Articles are published in both a web version and PDF format.
Article Processing Charges
Journal of Endoluminal Endourology, like other Open Access journals, charges Article Processing Charges (APC) to individual authors and institutions to offset expenses usually covered by the subscriptions and advertisements of subscription-based journals. APCs are per article and billed upon acceptance of an article, after it has successfully passed the peer review process. There are no additional charges based on color, length, figures, or other elements. Letters to the Editor and small commentaries (up to 250 words), and select invited articles are not charged an APC. There is no charge for submitting articles; authors are only charged for accepted articles.
An author’s ability to pay APCs is not a consideration in the decision of whether to publish. Authors living in one of the United Nations' list of Least Developed Countries may request a fee waiver. See country list here. Authors living in countries not considered "least developed" who do not have the ability to pay the APC's may be eligible for a reduced rate. Please contact the publisher directly at email@example.com.
Starting January 1, 2019 the Article Processing Charge of US $199 will be charged for the Journal of Endoluminal Endourology.
All articles published in the JELEU are archived through Portico and assigned a unique DOI through CrossRef. All Published articles will also be included in Science Open. Visit Portico's website for more information.
Best Practice Policies
DPG has enlisted the help of a Publishing Advisory Board to help us develop, monitor, and maintain best practice policies and procedures when it comes to our Open Access publishing program. DPG is a fee-based Open Access publisher and authors pay an APC (Article Processing Charge) for articles that are accepted for publication (after a rigorous peer review process). These fees differ from journal to journal. Please see individual titles for actual price.
Criteria for Publishing
All articles published in DPG Open Access journals are licensed under
Corrections - Retractions
In the event of a correction is needed within an article, the author will notify the publisher immediately and outline the correction required. This request will be sent to, and reviewed by, the Editor who may ask members of the Editorial Board for input. Once the correction has been established, and addendum to the original article will be published and the full-corrected article will be published on line. A retraction request will be considered by the Editor/Associate Editors in conjunction with Editorial Board members. Once an article has been retracted a notice of retraction will be published disclosing the reasons for the retraction.
For manuscripts reporting medical studies involving human participants, authors are asked to provide a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards. Authors are encouraged to take adequate steps to minimize harm to participants, to avoid coercion or exploitation, to protect confidentiality, and to minimize the risk of physical and psychological harm.
In biomedical sciences, editors should consider only publishing information and images from individual participants where the authors have obtained the individual free prior informed consent. Research involving animals should be conducted with the same rigor as research in humans. Authors should confirm that ethical and legal approval was obtained prior to the start of the study, and state the name of the body giving the approval. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines and regulations.
Authors should protect the confidentiality of individual information this is obtained through the doctor–patient relationship. Authors must obtain written informed consent from patients described in case reports/articles and for photographs of patients. It may be possible for an author to publish with our explicit consent in cases where patient consent is not readily available or accessible.
Ethics and Transparency